AU6565100A - Liquid pharmaceutical composition based on paracetamol - Google Patents

Liquid pharmaceutical composition based on paracetamol

Info

Publication number
AU6565100A
AU6565100A AU65651/00A AU6565100A AU6565100A AU 6565100 A AU6565100 A AU 6565100A AU 65651/00 A AU65651/00 A AU 65651/00A AU 6565100 A AU6565100 A AU 6565100A AU 6565100 A AU6565100 A AU 6565100A
Authority
AU
Australia
Prior art keywords
paracetamol
pharmaceutical composition
liquid pharmaceutical
composition based
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65651/00A
Inventor
Alberto Campana
Giovanni Cavallo
Mario Pinza
Vilma Rossi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Publication of AU6565100A publication Critical patent/AU6565100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU65651/00A 1999-07-30 2000-07-18 Liquid pharmaceutical composition based on paracetamol Abandoned AU6565100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI99A001697 1999-07-30
IT1999MI001697A IT1313579B1 (en) 1999-07-30 1999-07-30 PARACETAMOL-BASED LIQUID PHARMACEUTICAL COMPOSITION.
PCT/EP2000/006871 WO2001008662A1 (en) 1999-07-30 2000-07-18 Liquid pharmaceutical composition based on paracetamol

Publications (1)

Publication Number Publication Date
AU6565100A true AU6565100A (en) 2001-02-19

Family

ID=11383451

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65651/00A Abandoned AU6565100A (en) 1999-07-30 2000-07-18 Liquid pharmaceutical composition based on paracetamol

Country Status (4)

Country Link
AR (1) AR024959A1 (en)
AU (1) AU6565100A (en)
IT (1) IT1313579B1 (en)
WO (1) WO2001008662A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862872A1 (en) * 2003-12-02 2005-06-03 Palbian Snc AQUEOUS COMPOSITION FOR THE PERFUSABLE APPLICATION OF AN ACTIVE, PARTICULARLY PHARMACOLOGICAL PRINCIPLE SUCH AS PARACETAMOL
US9585849B2 (en) 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
ES2424872T3 (en) 2007-08-07 2013-10-09 Stellenbosch University Paracetamol for use in the treatment of glaucoma
EP2243477A1 (en) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
PE20170426A1 (en) * 2010-06-30 2017-04-12 Troikaa Pharmaceuticals Ltd PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME
IT1403660B1 (en) * 2011-01-28 2013-10-31 Abiogen Pharma Spa PHARMACEUTICAL COMPOSITION LIQUID CONTAINING PARACETAMOL
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US20150141518A1 (en) * 2013-11-21 2015-05-21 Emphascience, Inc. Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US20160144033A1 (en) * 2014-11-21 2016-05-26 Emphascience, Inc. Concentrated acetaminophen solution
TN2017000232A1 (en) 2014-12-20 2018-10-19 Troikaa Pharmaceuticals Ltd Injectable formulations of paracetamol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION

Also Published As

Publication number Publication date
WO2001008662A1 (en) 2001-02-08
ITMI991697A1 (en) 2001-01-30
IT1313579B1 (en) 2002-09-09
ITMI991697A0 (en) 1999-07-30
AR024959A1 (en) 2002-10-30

Similar Documents

Publication Publication Date Title
HK1045650A1 (en) Pharmaceutical composition.
AU1071301A (en) Pharmaceutical compounds
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AP2003002907A0 (en) Liquid pharmaceutical composition.
AU2919001A (en) Syringe
AU5326100A (en) Pharmaceutical compositions and methods for use
AU3556400A (en) Pharmaceutical compositions
AU1887401A (en) Medicinal composition
AU4328800A (en) Pharmaceutical formulation
AU6565100A (en) Liquid pharmaceutical composition based on paracetamol
ZA200000857B (en) Pharmaceutical composition.
AU1735001A (en) Cyclodextrin-containing pharmaceutical composition
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
PL345767A1 (en) Pharmaceutical composition for injection based on paracetamol
AU5754100A (en) Liquid herbicide composition
HK1035913A1 (en) Liquid crystal composition.
AU2792700A (en) Pharmaceutical composition containing cyclosporin
AU5460800A (en) Pharmaceutical transdermal compositions
AU6460400A (en) Pharmaceutical compositions
AU9343098A (en) Pharmaceutical composition
AU5722900A (en) Pharmaceutical compounds
AU6460200A (en) Pharmaceutical compositions
AU3839900A (en) Pharmaceutical formulation
AU6460300A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase